The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling
Open accessAbstract
Hypoxia induces rapid and dramatic changes in cellular metabolism, in part through inhibition of target of rapamycin (TOR) kinase complex 1 (TORC1) activity. Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells. The molecular mechanism and physiologic significance of this effect of hypoxia remain unknown. Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14–3–3 proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14–3–3 and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to bind 14–3–3 are defective in eliciting TSC2/14–3–3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1. In vitro, loss of REDD1 signaling promotes proliferation and anchorage-independent growth under hypoxia through mTORC1 dysregulation. In vivo, REDD1 loss elicits tumorigenesis in a mouse model, and down-regulation of REDD1 is observed in a subset of human cancers. Together, these findings define a molecular mechanism of signal integration by TSC1/2 that provides insight into the ability of REDD1 to function in a hypoxia-dependent tumor suppressor pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recent study showed that endogenous Redd1 is required for both dissociation of endogenous TSC2/14–3-3 proteins and inhibition of mTOR in response to hypoxia [127].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [127]
In the citing paper
“Another example of this localization dependency includes hypoxia-dependent regulation through REDD1 (Brugarolas et al., 2004), which disrupts cytosolic 14-3-3-bound TSC2 and enables subsequent TSC2 localization to the lysosome where it can inhibit Rheb (DeYoung et al., 2008).”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as DeYoung et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,590
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Self-citationGene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J., van de Rijn, M., Bair, E., Montgomery, K. D., Ferrari, M. K., Egevad, L., Rayford, W., Bergerheim, U. S. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,282
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 710
Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition
Damerill, I., Biggar, K. K., Shehab, M. A., Li, S. S. ‐., Jansson, T., & Gupta, M. B. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1194 · Cited by 27
Targeting the mTOR pathway in breast cancer
Liu, J., Li, H., Zhou, F.-X., Yu, J.-W., Sun, L., & Han, Z.-H. (2017) · Tumor Biology · doi:10.1177/1010428317710825 · Cited by 27
Baida, G. E., Bhalla, P., Yemelyanov, A. Y., Stechschulte, L. A., Shou, W., Readhead, B., Dudley, J. T., Sánchez, E. R., & Budunova, I. V. (2018) · Oncotarget · doi:10.18632/oncotarget.26194 · Cited by 28
Nutrient-Mediated Perception and Signalling in Human Metabolism: A Perspective of Nutrigenomics
Lal, M. K., Sharma, E., Tiwari, R. K., Devi, R., Mishra, U. N., Thakur, R., Gupta, R., Dey, A., Lal, P., Kumar, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911305 · Cited by 30
The role of TSC2 in breast cancer: a literature review
Zhu, Q., He, Z.-M., Cao, W., & Li, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1188371 · Cited by 26
Lan, Y.-C., Chang, C.-L., Sung, M., Yin, P., Hsu, C., Wang, K.-C., Lee, H., Tseng, L., & Chi, C. (2013) · PubMed · Cited by 26
Sustained overexpression of Redd1 leads to Akt activation involved in cell survival
Jin, H., Hong, S., Kim, J., Choi, H.-N., Kim, K., An, S., Choe, T., Hwang, C.-S., Lee, J. H., Kim, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.021 · Cited by 26
del Olmo‐Aguado, S., Núñez‐Álvarez, C., Ji, D., Manso, A. G., & Osborne, N. N. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.08.002 · Cited by 26
Hypoxia‐induced regulation of mTOR signaling by miR‐7 targeting REDD1
Seong, M., Lee, J., & Kang, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27740 · Cited by 29
Coyne, E. S., Bedard, N., Wykes, L., Stretch, C., Jammoul, S., Li, S., Zhang, K., SLADEK, R. M., Bathe, O. F., Jagoe, R. T., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00290 · Cited by 28
The Andes Virus Nucleocapsid Protein Directs Basal Endothelial Cell Permeability by Activating RhoA
Gorbunova, E. E., Simons, M. J., Gavrilovskaya, I. N., & Mackow, E. R. (2016) · mBio · doi:10.1128/mbio.01747-16 · Cited by 25
Sinha, I., Allen, J. E., Pinto, J. T., & Sinha, R. (2014) · Cancer Medicine · doi:10.1002/cam4.198 · Cited by 25
Li, C., Fang, Y., & Chen, Y. M. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.011 · Cited by 24
Hypoxia and gerosuppression: The mTOR saga continues
Leontieva, O. V., & Blagosklonny, M. V. (2012) · Cell Cycle · doi:10.4161/cc.21908 · Cited by 25
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
Ianniciello, A., Dumas, P., Drullion, C., Guitart, A. V., Villacreces, A., Peytour, Y., Chevaleyre, J., de la Grange, P. B., Vigon, I., Desplat, V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18904 · Cited by 26
GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels
Kanno, A., Asahara, S.-I., Furubayashi, A., Masuda, K., Yoshitomi, R., Suzuki, E., Takai, T., Kimura-Koyanagi, M., Matsuda, T., Bartolomé, A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.128820 · Cited by 24
REDD1 deletion attenuates cancer cachexia in mice
Hain, B. A., Xu, H., VanCleave, A. M., Gordon, B. S., Kimball, S. R., & Waning, D. L. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00536.2021 · Cited by 24
Liu, P., Hu, Y., Wang, M.-J., & Kang, L. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.10.001 · Cited by 25
Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences
Çam, H., & Houghton, P. J. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0173-x · Cited by 25
Endurance exercise decreases protein synthesis and ER-mitochondria contacts in mouse skeletal muscle
Merle, A., Jollet, M., Britto, F. A., Goustard, B., Bendridi, N., Rieusset, J., Ollendorff, V., & Favier, F. B. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00196.2019 · Cited by 28
Tiana, M., Acosta-Iborra, B., Hernández, R., Galiana, C., Fernández-Moreno, M. Á., Jimenez, B., & del Peso, L. (2020) · RNA · doi:10.1261/rna.072611.119 · Cited by 23
Sabeel, Z., Liang, Y., Hao, M., Lu, Y., Guo, R., Chen, R., Li, X., Yu, C., & Yang, Z. (2023) · Phytotherapy Research · doi:10.1002/ptr.7841 · Cited by 23
Lane, S. L., Doyle, A. S., Bales, E. S., Lorca, R. A., Julian, C. G., & MOORE, L. G. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz208 · Cited by 23
Sodium bicarbonate, an inorganic salt and a potential active agent for cancer therapy
Wang, Y., Zhou, X., Wang, W., Wu, Y., Qian, Z., & Peng, Q. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.06.032 · Cited by 22
Tian, D., Patton, A. H., Turner, B. J., & Martin, C. H. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.1561 · Cited by 25
mTOR and its tight regulation for iNKT cell development and effector function
Yang, W., Gorentla, B. K., Zhong, X., & Shin, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.022 · Cited by 23
A herpesvirus kinase that masquerades as Akt
Chuluunbaatar, U., & Mohr, I. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16242 · Cited by 23
Valenzuela, C., Escobar, D., Perez, L., Zuloaga, R., Estrada, J. M., Mercado, L. A., Valdés, J. A., & Molina, A. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.06.007 · Cited by 23
REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high‐fat diet
Dumas, K., Ayachi, C., Gilleron, J., Lacas‐Gervais, S., Pastor, F., Favier, F. B., Peraldi, P., Vaillant, N., Yvan‐Charvet, L., Bonnafous, S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901799rr · Cited by 23
Protein Phosphorylation as a Key Mechanism of mTORC1/2 Signaling Pathways
Tchevkina, E. M., & Komelkov, A. V. (2012) · InTech eBooks · doi:10.5772/48274 · Cited by 26
Bird, S. P., Nienhuis, M. B., Biagioli, B., Pauw, K. D., & MEEUSEN, R. R. (2024) · Nutrients · doi:10.3390/nu16121886 · Cited by 27
Kim, Y. S., Kimball, S. R., Piskounova, E., Begley, T. J., & Hempel, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317846121 · Cited by 24
Cell plasticity in regeneration in the stomach and beyond
Adkins-Threats, M., & Mills, J. C. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101948 · Cited by 23
Pan, X., Liu, C., Wang, X., Zhao, M., Zhang, Z., Zhang, X., Wang, C., & Song, G. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13068 · Cited by 22
Redd1 inhibits the invasiveness of non-small cell lung cancer cells
Jin, H., Seo, S., Woo, S., Kim, Y., Hong, S., Yi, J.-Y., Noh, W.-C., Kim, E., Lee, J., Hong, S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.047 · Cited by 23
Hirao, A., & Hoshii, T. (2013) · Cancer Science · doi:10.1111/cas.12189 · Cited by 24
PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4
Salsman, J., Stathakis, A., Parker, E., Chung, D., Anthes, L. E., Koskowich, K. L., Lahsaee, S., Gaston, D., Kukurba, K. R., Smith, K. S., et al. (2017) · Scientific Reports · doi:10.1038/srep45038 · Cited by 20
Zhang, Y., Zhang, H., Zhang, B., Ling, Y., & Zhang, H. (2019) · Gene · doi:10.1016/j.gene.2019.144321 · Cited by 24
Familial Mediterranean fever: the molecular pathways from stress exposure to attacks
Korkmaz, C., Cansu, D. Ü., & Cansu, G. B. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa450 · Cited by 23
Bringing Light to Chronic Obstructive Pulmonary Disease Pathogenesis and Resilience
Tuder, R. M. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-583mg · Cited by 22
Evren, S., Dermen, A., Lockwood, G. A., Fleshner, N. E., & Sweet, J. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200083 · Cited by 21
Origins and molecular effects of hypoxia in cancer
Rey-Keim, S., & Schito, L. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.10.001 · Cited by 22
Lee, C. H., Park, J. H., Cho, J.-H., Ahn, J. H., Yan, B. C., Lee, J., Shin, M. C., Cheon, S. H., Cho, Y. S., Cho, J. H., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.016 · Cited by 20
cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features
Nourian, Y. H., Salimian, J., Ahmadi, A., Salehi, Z., Karimi, M., Emamvirdizadeh, A., Jamalkandi, S. A., & Ghanei, M. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101438 · Cited by 21
Wang, T., Zeng, L., Wei, Q., Yang, Y., Tao, Y., Chang, L., Wu, X., Meng, Z., & Liu, X. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.740827 · Cited by 19
Targeting Rb inactivation in cancers by synthetic lethality.
Gordon, G. M., & Du, W. (2011) · PubMed · Cited by 20
Zhou, Y., Wang, Q., Guo, Z., Weiss, H. L., & Evers, B. M. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-01-0037 · Cited by 22
Zhou, Y., Wang, Q., Weiss, H. L., & Evers, B. M. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0998 · Cited by 20
Matak, D., Brodaczewska, K. K., Lipiec, M., Szymański, Ł., Szczylik, C. A., & Czarnecka, A. M. (2017) · Cytotechnology · doi:10.1007/s10616-016-0063-2 · Cited by 21
Tiwarekar, V., Wohlfahrt, J., Fehrholz, M., Scholz, C. J., Kneitz, S., & Schneider‐Schaulies, J. (2018) · Journal of Virology · doi:10.1128/jvi.00835-18 · Cited by 20
Feng, Y., Song, K., Shang, W., Chen, L., Wang, C., Pang, B., & Wang, N. (2019) · Oncology Letters · doi:10.3892/ol.2019.11070 · Cited by 20
Dungan, C. M., Li, J., & Williamson, D. L. (2016) · Lipids · doi:10.1007/s11745-016-4168-3 · Cited by 20
Celik, S., Celikkan, F. T., Özkavukçu, S., Can, A., & Çelik-Özenci, Ç. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1140-6 · Cited by 19
Margolis, L. M., Carbone, J. W., Berryman, C. E., Carrigan, C. T., Murphy, N. E., Ferrando, A. A., Young, A., & Pasiakos, S. M. (2018) · The FASEB Journal · doi:10.1096/fj.201800163rr · Cited by 19
Furuya, N., Kamai, T., Shirataki, H., Yanai, Y., Fukuda, T., Mizuno, T., Nakamura, F., Kambara, T., Nakanishi, K., Abe, H., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0989-3 · Cited by 18
Nogami, A., Okada, K., Ishida, S., Akiyama, H., Umezawa, Y., & Miura, O. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.001 · Cited by 18
Moberg, M., Apró, W., Horwath, O., van Hall, G., Blackwood, S. J., & Katz, A. (2022) · Acta Physiologica · doi:10.1111/apha.13771 · Cited by 17
Zhang, K., Zhao, Y., Chen, X., Li, Y., Lan, T., Chang, M., Wang, W., Wang, C., Zhuang, X., Zhang, B., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103836 · Cited by 21
Jiang, C., Liu, X., Wang, M., Lv, G., & Wang, G. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15456687424096 · Cited by 17
RetractedTang, H., Tan, C., Cao, X., Liu, Y., Zhao, H., Liu, Y., & Zhao, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.692781 · Cited by 17
RetractedPark, M., Kim, J., Kim, T., Kim, S., Park, W., Ha, K., Cho, S. H., Won, M., Lee, J., Kwon, Y., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00690-z · Cited by 17
Yue, Y., Tang, Y., Huang, H., Zheng, D., Liu, C., Zhang, H., Liu, Y., Li, Y., Sun, X., & Lu, L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104829 · Cited by 17
Hu, J., Fu, S., Zhan, Z., & Zhang, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116109 · Cited by 19
p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect
Abukwaik, R., Vera-Sigüenza, E., Tennant, D. A., & Spill, F. (2024) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01346-5 · Cited by 19
Whirledge, S., Kisanga, E. P., Taylor, R. N., & Cidlowski, J. A. (2017) · Endocrinology · doi:10.1210/en.2017-00361 · Cited by 17
Dungan, C. M., Gordon, B. S., & Williamson, D. L. (2019) · Physiological Reports · doi:10.14814/phy2.14011 · Cited by 16
Evagelou, S. L., Bebenek, O., Specker, E. J., & Uniacke, J. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00610-19 · Cited by 20
Tumor hypoxia and genetic alterations in sporadic cancers
Koi, M., & Boland, C. R. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01377.x · Cited by 17
Decaux, O., Clément, M., Magrangeas, F., Gouraud, W., Guérin‐Charbonnel, C., Campion, L., Avet‐Loiseau, H., & Minvielle, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01467.x · Cited by 22
Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
Patel, S., Prajapati, C., Nand, S., & Singh, S. K. (2026) · 3 Biotech · doi:10.1007/s13205-026-04697-z · Cited by 16
Li, J., Quan, C., He, Y., Cao, Y., Chen, Y., Wang, Y., & Wu, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.896893 · Cited by 17
Evren, S., Dermen, A., Lockwood, G., Fleshner, N. E., & Sweet, J. (2010) · The Prostate · doi:10.1002/pros.21178 · Cited by 16
Multimodality Approaches to Treat Hypoxic Non-Small Cell Lung Cancer (NSCLC) Microenvironment
Liang, S., Galluzzo, P., Sobol, A., Skucha, S., Rambo, B., & Bocchetta, M. (2012) · Genes & Cancer · doi:10.1177/1947601912457025 · Cited by 16
Koo, J. S., & Jung, W. (2010) · Pathobiology · doi:10.1159/000320936 · Cited by 16
Pivonello, C., Rousaki, P., Negri, M., Sarnataro, M., Napolitano, M., Marino, F. Z., Patalano, R., Martino, M. C. D., Sciammarella, C., Faggiano, A., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1079-2 · Cited by 16
Ghosh, J., & Kapur, R. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0067-z · Cited by 15
Could metformin be therapeutically useful in Huntington’s disease?
Tang, B. L. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0072 · Cited by 15
Park, M., Kim, J. Y., Kim, J., Lee, J., Kwon, Y., & Kim, Y. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.9.096 · Cited by 15
Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia
Uchenunu, O., Pollak, M., Topisirović, I., & Hulea, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0058 · Cited by 16
Hepatic Endoderm Differentiation from Human Embryonic Stem Cells
Hannoun, Z., Filippi, C., Sullivan, G. J., Hay, D. C., & Iredale, J. P. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810791824403 · Cited by 14
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells
Panuzzo, C., Pironi, L., Maglione, A., Rocco, S., Stanga, S., Riganti, C., Kopecka, J., Ali, M. S., Pergolizzi, B., Bracco, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021234 · Cited by 14
Gai, C., Xing, X., Song, Y., Zhao, Y., Jiang, Z., Cheng, Y., Xiao, Y., & Wang, Z. (2023) · Drug Design, Development and Therapy · doi:10.2147/dddt.s393362 · Cited by 14
Wang, Y., Engel, T., & Teng, X. (2024) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2024.195005 · Cited by 13
The role of mTOR signalling pathway in hypoxia-induced cognitive impairment
Qaid, E. Y. A., Zulkipli, N. N., Zakaria, R., Ahmad, A. H., Othman, Z., Muthuraju, S., & Sasongko, T. H. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1746308 · Cited by 13
Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats
Batista, K. N. I., Schraner, M., & Riediger, T. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108289 · Cited by 12
REDD1 Is Involved in Amyloid β-Induced Synaptic Dysfunction and Memory Impairment
Yi, J. H., Kwon, H., Cho, E., Jeon, J., Lee, J., Lee, Y. C., Cho, J. H., Jun, M., Moon, M., Ryu, J. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249482 · Cited by 14
Luo, J., Odaka, Y., Huang, Z., Cheng, B., Liu, W., Li, L., Shang, C., Zhang, C., Wu, Y., Luo, Y., et al. (2021) · Cells · doi:10.3390/cells10061363 · Cited by 13
Saliu, T. P., Kumrungsee, T., Miyata, K., Tominaga, H., Yazawa, N., Hashimoto, K., Kamesawa, M., & Yanaka, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120183 · Cited by 13
Smoking and emphysema: the stress connection
Ellisen, L. W. (2010) · Nature Medicine · doi:10.1038/nm0710-754 · Cited by 13
Self-citationVaiou, M., Pangou, E., Liakos, P., Sakellaridis, N., Vassilopoulos, G., DIMAS, K. S., & Papandreou, C. N. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2216-2 · Cited by 13
Tsc2 mutation induces renal tubular cell nonautonomous disease
Kumar, P., Zadjali, F., Yao, Y., Johnson, D. L., Siroky, B. J., Astrinidis, A., Vogel, P., Gross, K. W., & Bissler, J. J. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.03.010 · Cited by 13
Signal integration in the (m)TORC1 growth pathway
Ramlaul, K., & Aylett, C. H. S. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1501-7 · Cited by 12
Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology
Sauvé, F., Gomez-Martínez, R., Mbouamboua, Y., Ternier, G., Nampoothiri, S. S., Dupré, E., Garcia, L., Couralet, M., Dewisme, J., Lebouvier, T., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100003 · Cited by 15
Derr, R. S., Moelijker, N., Hendriks, G., & Brandsma, I. (2022) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2022.105120 · Cited by 12
Fallone, L., Walzer, T., & Marçais, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612736 · Cited by 13
Ma, Y., Li, Y., Ling, S., Li, X., Kong, B., Hu, M., & Huang, P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.137 · Cited by 12
Multifaceted control of mRNA translation machinery in cancer
Alboushi, L., Hackett, A. P., Naeli, P., Bakhti, M., & Jafarnejad, S. M. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110037 · Cited by 13
Autophagy Is Essential for Neural Stem Cell Proliferation Promoted by Hypoxia
Li, J., Gong, S.-H., He, Y., Cao, Y., Chen, Y., Huang, G.-H., Wang, Y., Zhao, M., Cheng, X., Zhou, Y., et al. (2022) · Stem Cells · doi:10.1093/stmcls/sxac076 · Cited by 12
Abdel‐Aziz, A. K., Dokla, E. M. E., Abouzid, K. A. M., & Minucci, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115316 · Cited by 13
Chapter 7 The Regulation of Protein Synthesis in Cancer
Cuesta, R., Gupta, M., & Schneider, R. J. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90007-2 · Cited by 12
Metadata
- Authors
- DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W.
- Affiliations
- Harvard University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2008-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 239-251
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC2192757
- OpenAlex
- W2130396048
- Cited by
- 710
- References
- 41
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 17 · 2023: 32 · 2022: 37 · 2021: 43 · 2020: 34 · 2019: 38 · 2018: 41 · 2017: 42 · 2016: 44 · 2015: 42 · 2014: 48 · 2013: 45 · 2012: 47
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA122589)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- hypoxia, TSC1/2, mTORC1, REDD1, 14-3-3 proteins, TORC1 inhibition, tumor suppression, anchorage-independent growth, carcinogenesis, cellular metabolism, signal integration
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Breast Neoplasms, Cells, Cultured, Humans, Mice, Nude, Models, Biological, Neoplasm Transplantation, Protein Kinases, Transcription Factors, Signal Transduction, Cell Hypoxia, Tumor Suppressor Proteins, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review